As of Jun 24
| -1.63 / -6.91%|
The 10 analysts offering 12-month price forecasts for Ionis Pharmaceuticals Inc have a median target of 30.50, with a high estimate of 59.00 and a low estimate of 12.00. The median estimate represents a +38.83% increase from the last price of 21.97.
The current consensus among 13 polled investment analysts is to Hold stock in Ionis Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.